Opioid Distributors Trial Begins With $95 Billion at Stake (1)

Nov. 15, 2021, 11:09 PM UTC

McKesson Corp. and two other drug distributors say they could end up having to pay more than $95 billion if they lose a trial in Seattle over the opioid crisis that began Monday.

Washington State Attorney General Robert Ferguson claims McKesson, Cardinal Health Inc. and AmerisourceBergen Corp. violated the state’s consumer-protection laws by turning a blind eye to red flags about opioid shipments. The companies failed to have tracking systems in place to prevent illegitimate sales and distribution of opioids as required by Washington’s state law, Ferguson said.

Evidence will show McKesson and the other distributors “displayed a callous ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.